15-valent HPV recombinant vaccine

HPV recombinant vaccine, 15-valent · Shanghai Bovax Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 15-valent HPV recombinant vaccine, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years [Phase 2]

See pricing